A gender difference in circulating neutrophils in malnourished patients with COPD

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 83-88

  Larsson, Sven ^a   Nordenson, Anita ^a   Glader, Pernilla ^a   Yoshihara, Shigemi ^b   Lindén, Anders ^a   Slinde, Frode ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Inflammatory markers; Leukocytosis; Malnutrition

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MALNUTRITION; NEUTROPHIL; NEUTROPHIL COUNT; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; LINEAR MODELS; LUNG; MALE; MALNUTRITION; NEUTROPHILS; NUTRITIONAL STATUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; SMOKING; SWEDEN;

EID: 79251528861     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S15351     Document Type: Article

References (22)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16.
2. The National Board of Health and Welfare (Socialstyrelsen). Hälso- och sjukvårdsrapport 2009. Socialstyrelsen, Stockholm, Sweden, 2009.
3. Cote CG, Chapman KR. Diagnosis and treatment considerations for women with COPD. Int J CLin Pract. 2009;63:486-493.
4. DeTorres JP, Campro A, Casanova C, Aguirre-Jaime A, Zuluenta J. Gender and chronic obstructive pulmonary disease in high risk smokers. Respiration. 2006;73:306-310.
5. Wouters E. COPD: from obstructive lung disease to chronic systemic inflammatory syndrome? Pneumologie. 2009;63(Suppl 2):S107-S112.
6. Broekhuizen R, Wouters EFM, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax. 2006;61:17-22.
7. Pinto-Plata VM, Mullerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006;61:23-28.
8. Gan WQ, Man SF. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax. 2004;59:574-580.
9. Chan-Yeung M, Abboud R, Buncio AD, Vedal S. Peripheral leucocyte count and decline in lung function. Thorax. 1988;43:462-466.
10. Higashimota Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Resp Med. 2009;103:1231-1238.
11. Olafsdottir IS, Gislason T, Thjodleifsson B, et al. Gender differences in the association between C-reactive protein, lung function impairment, and COPD. Int J Chron Obstruct Pulmon Dis. 2007;2:635-642.
12. Nordenson A, Grönberg AM, Hulthén L, Larsson S, Slinde F. A validated disease specific prediction equation for resting metabolic rate in underweight patients with COPD. Int J COPD. 2010;5:271-276.
13. Hafner G, Erbes H, Drosdat H, Lotz J, Ehrental W, Wurzburg U. Evaluation of a new assay for the determination of PMN elastase-a-1- proteinase inhibitor complexes in EDTA and citrated plasma. Clin Laboratory. 1997;43:3-9.
14. Yoshihara S, Yamada Y, Abe T, Lindén A, Arisaka O. Association of epithelial damage and signs of neutrophil mobilization in the airways during acute exacerbations of pediatric asthma. Clin Exp Immunol. 2006;144:212-216.
15. Furth V. Development and distribution of mononuclear phagocytes. In: Gallin JIGI, Snyderman R, editors. Inflammation. Basic Principles and Clinical Correlates. 2nd ed. New York: Raven Press;1992:325-51.
16. Blaiss MS, Herrod HG, Crawford LV, Lieberman PL. Beclomethasone dipropionate aerosol: hematologic and immunologic effects. Ann Allergy. 1982;48:210-214.
17. Bishop CR, Athens JW, Boggs DR, Warner HR, Cartwright GE, Wintrobe MM. Leukokinetic studies: a non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis. J Clin Invest. 1968;47:249-260.
18. Wollin L, Pieper MP. Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm Pharmacol Ther. 2010;23:345-354.
19. Nilsson BO. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytosis. Inflamm Res. 2007;56:269-273.
20. Barzilay J, Blaum C, Moore T. Insulin resistance and inflammation as precursors of frailty: the cardiovascular health study. Arch Intern Med. 2007;167:635-641.
21. Emerging Risk Factors Collaboration, Kaptoge S, di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;9:132-140.
22. Carlsson L, Lind L, Larsson A. Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology. 2009;56: 259-265.